{"schema_version":"secwatch.filing_event.v1","accession":"0001079973-25-001707","form_type":"8-K","ticker":"TOI","cik":"0001799191","company_name":"Oncology Institute, Inc.","filed_at":"2025-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.493486+00:00","generated_at":"2026-05-16T20:30:07.499763+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"confidence":"high","headline":"TOI Q3 revenue $136.6M (+37% YoY); adjusted loss narrows, raises FY 2025 guidance","bullets":["Consolidated revenue $136.6M (+36.7% YoY); gross profit $18.9M (+31.7%); net loss $(16.5)M vs $(16.1)M.","Adjusted EBITDA improved to $(3.5)M from $(8.2)M; diluted EPS $(0.14) vs $(0.18) loss per share.","Retail pharmacy revenue $75.9M, set fill records, contributed $12.8M gross profit.","Fee-for-service revenue grew 13% YoY on organic growth in Florida and Oregon.","Full year 2025 guidance raised (specific figures not disclosed in filed excerpt)."],"urls":{"canonical":"https://secwatch.observer/filing/0001079973-25-001707","json":"https://secwatch.observer/filing/0001079973-25-001707.json","markdown":"https://secwatch.observer/filing/0001079973-25-001707.md","text":"https://secwatch.observer/filing/0001079973-25-001707.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799191/000107997325001707/0001079973-25-001707-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799191/000107997325001707/toi_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T20:30:07.499763+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}